2. UroToday Home
  3. Recent Abstracts
  4. Pelvic Health & Reconstruction
  5. Overactive Bladder

Oxybutynin-Associated Cognitive Impairment: Evidence and Implications for Overactive Bladder Treatment - Beyond the Abstract

Anticholinergic medications have long been mainstays of overactive bladder (OAB) treatment. Oxybutynin, a first-generation anticholinergic, still accounts for more than half of all OAB medication prescriptions, despite associations with impaired memory and cognition, as well as mounting evidence that it may increase the risk of incident dementia.

Oxybutynin-Associated Cognitive Impairment: Evidence and Implications for Overactive Bladder Treatment - Beyond the Abstract



Michael Chancellor, MD, Corewell Health Beaumont University Hospital, Oakland University William Beaumont School of Medicine, Royal Oak, MI

Read the Abstract